Cover Image
市場調查報告書

甲狀腺性突眼症 (葛列夫氏眼病變):全球臨床實驗趨勢

Graves' Ophthalmopathy Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 339399
出版日期 內容資訊 英文 73 Pages
訂單完成後即時交付
價格
Back to Top
甲狀腺性突眼症 (葛列夫氏眼病變):全球臨床實驗趨勢 Graves' Ophthalmopathy Global Clinical Trials Review, H2, 2015
出版日期: 2015年07月31日 內容資訊: 英文 73 Pages
簡介

甲狀腺性突眼症 (葛列夫氏眼病變) 是眼睛的自體免疫疾病,是瑞夫茲氏病患者可能發生的眼科疾病。

本報告提供甲狀腺性突眼症 (葛列夫氏眼病變) 臨床實驗相關之最新趨勢分析,提供您各地區主要國家的臨床實驗數量,彙整臨床實驗的各階段進展,實驗對象採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 甲狀腺性突眼症 (葛列夫氏眼病變)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:眼科疾病治療藥臨床實驗上甲狀腺性突眼症 (葛列夫氏眼病變) 的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病治療藥臨床實驗上甲狀腺性突眼症 (葛列夫氏眼病變) 的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

甲狀腺性突眼症 (葛列夫氏眼病變) 治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • River Vision Development Corp.
    • Premier Research Group Limited
    • Novartis AG
    • Neothetics, Inc.
    • Ipsen S.A.
    • GlaxoSmithKline Plc
    • Genmab A/S
    • Fresenius Biotech GmbH (Inactive)
    • Barwon Health
    • Allergan Plc
  • 有代表性的研究機關·醫院臨床實驗概要
    • Sun Yat-sen University
    • Academic Medical Center
    • Medical University of Vienna
    • Agostino Gemelli University Polyclinic
    • Ankara University
    • California Pacific Medical Center Research Institute
    • Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
    • Hospices Civils de Lyon
    • Hospital Clinico Universitario Santiago de Compostela
    • Institute of Post Graduate Medical Education And Research

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2803CTIDB

GlobalData's clinical trial report, "Graves' Ophthalmopathy Global Clinical Trials Review, H2, 2015" provides an overview of Graves' Ophthalmopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Graves' Ophthalmopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Graves' Ophthalmopathy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Graves' Ophthalmopathy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Graves' Ophthalmopathy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • River Vision Development Corp.
      • Clinical Trial Overview of River Vision Development Corp.
      • Premier Research Group Limited
      • Clinical Trial Overview of Premier Research Group Limited
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Neothetics, Inc.
      • Clinical Trial Overview of Neothetics, Inc.
      • Ipsen S.A.
      • Clinical Trial Overview of Ipsen S.A.
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Genmab A/S
      • Clinical Trial Overview of Genmab A/S
      • Fresenius Biotech GmbH (Inactive)
      • Clinical Trial Overview of Fresenius Biotech GmbH (Inactive)
      • Barwon Health
      • Clinical Trial Overview of Barwon Health
      • Allergan Plc
      • Clinical Trial Overview of Allergan Plc
    • Clinical Trial Overview of Top Institutes / Government
      • Sun Yat-sen University
      • Clinical Trial Overview of Sun Yat-sen University
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Agostino Gemelli University Polyclinic
      • Clinical Trial Overview of Agostino Gemelli University Polyclinic
      • Ankara University
      • Clinical Trial Overview of Ankara University
      • California Pacific Medical Center Research Institute
      • Clinical Trial Overview of California Pacific Medical Center Research Institute
      • Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
      • Clinical Trial Overview of Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
      • Hospices Civils de Lyon
      • Clinical Trial Overview of Hospices Civils de Lyon
      • Hospital Clinico Universitario Santiago de Compostela
      • Clinical Trial Overview of Hospital Clinico Universitario Santiago de Compostela
      • Institute of Post Graduate Medical Education And Research
      • Clinical Trial Overview of Institute of Post Graduate Medical Education And Research
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Region, 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Graves' Ophthalmopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Graves' Ophthalmopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Graves' Ophthalmopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Graves' Ophthalmopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Graves' Ophthalmopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by River Vision Development Corp., 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Premier Research Group Limited, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Neothetics, Inc. , 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Genmab A/S, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Fresenius Biotech GmbH (Inactive), 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Barwon Health, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Agostino Gemelli University Polyclinic, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ankara University, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by California Pacific Medical Center Research Institute, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinico Universitario Santiago de Compostela, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Post Graduate Medical Education And Research, 2015*

List of Figures

  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Graves' Ophthalmopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Graves' Ophthalmopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Graves' Ophthalmopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Graves' Ophthalmopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Graves' Ophthalmopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Graves' Ophthalmopathy Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Graves' Ophthalmopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Graves' Ophthalmopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top